CD3+TCRValpha7.2 + T cell culture medium and multiplication culture method
A technology of expansion culture and culture medium, applied in the field of CD3+TCRVα7.2+T cell culture medium and expansion culture, it can solve the problems of low proportion of MAIT cells, easy pollution, difficult operation, etc., and achieve high cell purity, The effect of high cell viability and reduced background value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0066] A. Take fresh PBMCs and place them in a 50mL centrifuge tube. If they are revived PBMCs, resuspend the cells in RPMI1640 medium containing 5-10% FBS at a density of 0.5E+06-2E+06 / mL. The flasks were incubated for 6 hours. Then resuspend with 10mL PBS, centrifuge at 1500rpm at a speed of liters 9 to 9 for 5 minutes, discard the supernatant, and repeat once.
[0067] B. Add an appropriate amount of sorting solution, mix well and count with trypan blue, and take 1E+06 cells at the same time, and measure the proportion of CD3+TCRVα7.2+T cells before sorting with a flow cytometer, see Figure 4 .
[0068] C. Add CD3 MicroBeads, human (Miltenyi Biotec) at an amount of 3 to 20 μL for every 0.5E+07 to 2E+07 cells, up to 100 μL, and add 80 to 120 μL for every 0.5E+07 to 2E+07 cells Add the sorting solution in an appropriate amount and mix the cells evenly.
[0069] D. Place the above-mentioned centrifuge tube with cells at 4°C, incubate in the dark for 15-30 minutes, take it ...
Embodiment 2
[0078] A. Take the PBMC in step S1, wash off the excess residue with PBS, discard the supernatant, add PBS to resuspend, count with trypan blue, adjust the density to 1E+07~3E+07 / 100μL, take 1E +06 cells were used as a negative control, and 0.5-5 μL of anti-human CD45 (Biolegend), anti-human CD3 antibody (Biolegend), anti-human TCRVα7.2 antibody (Biolegend) and anti-human CD161 antibody (Biolegend) were added to each 100 μL ), mix well and incubate at room temperature for 10-30 minutes.
[0079] B. Add 10 mL of PBS, centrifuge at a speed of 1500 rpm for 5 minutes, discard the supernatant, and repeat once.
[0080] C. Cells were resuspended in T009 medium containing 3-10% FBS and 0.5-3% double antibody, and the density was 5E+06-3E+07 / mL.
[0081] D. Use BD Influx flow sorting instrument, adopt four-way sorting, collect CD45+CD3+TCRVα7.2+CD161+, CD45+CD3+TCRVα7.2+CD161-, CD45+CD3+TCRVα7.2-CD161- three kind of cells. The purity of the collected cells was detected by a flow cy...
Embodiment 3
[0083] A. Take the PBMC in step S1, wash away the excess residue with PBS, discard the supernatant, add PBS to resuspend, count with trypan blue, first use magnetic beads to sort out CD3+ T cells, and then add 5~ Centrifuge 15mL PBS at 1500rpm at a speed of liters 9 to 9 for 5 minutes, discard the supernatant, and repeat once.
[0084] B. Add an appropriate amount of PBS, adjust the density to 0.5E+07~3E+07 / 100μL, take 1E+06 cells as a negative control, add 0.5~5μL of anti-human CD3 antibody (Biolegend), anti -human TCRVα7.2 antibody (Biolegend) and anti-human CD161 antibody (Biolegend), mix well and incubate at room temperature for 10-30 minutes.
[0085] C. Add 5-15mL PBS, centrifuge at 1500rpm at a speed of 9 to 9 for 5 minutes, discard the supernatant, and repeat once.
[0086] D. Resuspend in T009 medium containing 3-10% FBS and 0.5-3% double antibody, and the density is 5E+06-3E+07 / mL.
[0087] E. Using a BD Influx flow sorter, four-way sorting was used to collect CD3+...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com